UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$948M |
| 2 |
Snowflake
SNOW
|
+$542M |
| 3 |
Sea Limited
SE
|
+$501M |
| 4 |
Procter & Gamble
PG
|
+$491M |
| 5 |
Snap
SNAP
|
+$403M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Infosys
INFY
|
+$434M |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$350M |
| 3 |
Lowe's Companies
LOW
|
+$215M |
| 4 |
Applied Materials
AMAT
|
+$186M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$183M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.21% |
| 2 | Healthcare | 13.25% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 12.28% |
| 5 | Communication Services | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Graham Holdings Company
GHC
$4.99B
| $2.86M | ﹤0.01% |
4,858
+450
| +10% | +$281K |
|
1627
Pacira BioSciences
PCRX
$974M
| $2.85M | ﹤0.01% |
50,891
| – | – |
|
1628
Arcosa
ACA
$7.11B
| $2.84M | ﹤0.01% |
56,678
| – | – |
|
1629
Worthington Enterprises
WOR
$2.79B
| $2.83M | ﹤0.01% |
87,239
| – | – |
|
1630
Plexus
PLXS
$7.16B
| $2.83M | ﹤0.01% |
31,655
+210
| +0.7% | +$18.7K |
|
1631
Pediatrix Medical
MD
$2.12B
| $2.83M | ﹤0.01% |
99,552
+28,701
| +41% | +$875K |
|
1632
Certara
CERT
$1.23B
| $2.8M | ﹤0.01% |
84,565
+36,496
| +76% | +$1.1M |
|
1633
CryoPort
CYRX
$747M
| $2.8M | ﹤0.01% |
42,065
+2,064
| +5% | +$127K |
|
1634
Stepan Co
SCL
$1.47B
| $2.8M | ﹤0.01% |
24,761
+259
| +1% | +$30.1K |
|
1635
Calix
CALX
$2.4B
| $2.79M | ﹤0.01% |
56,503
-1,138
| -2% | -$52.5K |
|
1636
FormFactor
FORM
$8.79B
| $2.79M | ﹤0.01% |
74,761
+996
| +1% | +$37.1K |
|
1637
Editas Medicine
EDIT
$432M
| $2.78M | ﹤0.01% |
67,633
+3,050
| +5% | +$167K |
|
1638
Vir Biotechnology
VIR
$1.5B
| $2.77M | ﹤0.01% |
63,719
+549
| +0.9% | +$23.8K |
|
1639
Plains GP Holdings
PAGP
$4.98B
| $2.77M | ﹤0.01% |
257,266
+987
| +0.4% | +$10.3K |
|
|
AVYA
1640
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $2.76M | ﹤0.01% |
139,350
+22,867
| +20% | +$504K |
|
1641
First Merchants
FRME
$2.66B
| $2.75M | ﹤0.01% |
65,830
| – | – |
|
|
MFA
1642
MFA Financial
MFA
$919M
| $2.74M | ﹤0.01% |
150,130
+14,006
| +10% | +$260K |
|
1643
Boot Barn
BOOT
$5.11B
| $2.74M | ﹤0.01% |
30,858
+3,055
| +11% | +$263K |
|
1644
Vroom Inc
VRM
$51.2M
| $2.73M | ﹤0.01% |
1,547
+188
| +14% | +$479K |
|
1645
Urban Outfitters
URBN
$6.81B
| $2.73M | ﹤0.01% |
91,902
-6,717
| -7% | -$240K |
|
|
FOLD
1646
DELISTED
Amicus Therapeutics
FOLD
| $2.73M | ﹤0.01% |
285,641
-39,196
| -12% | -$401K |
|
1647
B&G Foods
BGS
$276M
| $2.73M | ﹤0.01% |
91,212
+4,270
| +5% | +$128K |
|
|
ESMT
1648
DELISTED
EngageSmart, Inc.
ESMT
| $2.72M | ﹤0.01% |
+80,000
| New | +$2.75M |
|
|
UHT
1649
Universal Health Realty Income Trust
UHT
$576M
| $2.72M | ﹤0.01% |
49,295
+649
| +1% | +$38.2K |
|
1650
Liberty Latin America Class C
LILAK
$1.65B
| $2.72M | ﹤0.01% |
228,183
-6,564
| -3% | -$81.5K |
|
Similar funds
UBS AM's Q3 2021 Portfolio in Review
As of Q3 2021, UBS AM held 2,809 positions worth $241B, up 3.2% from $234B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM deployed $8.13B of net new capital in Q3 2021, opening 56 new positions and adding to 1,358 existing holdings. Its largest new stake was State Street SPDR Portfolio Intermediate Term Treasury ETF: 6,053,315 shares worth $196M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Infosys, an estimated $434M trimmed.
- UBS AM's largest Q3 2021 buy was State Street SPDR Portfolio Intermediate Term Treasury ETF: 6,053,315 shares worth $196M.
- UBS AM added most to Microsoft in Q3 2021, an estimated $948M increase.
- UBS AM's biggest Q3 2021 reduction was Infosys, cutting an estimated $434M.
- UBS AM fully exited Vanguard Short-Term Treasury ETF in Q3 2021, selling an estimated $350M.
- UBS AM's ten largest holdings make up 22% of its $241B portfolio in Q3 2021.
- UBS AM opened 56 new positions and closed 62 in Q3 2021.
- UBS AM's portfolio value rose 3.2% quarter-over-quarter to $241B.
Based on UBS AM's 13F filing for Q3 2021, filed 15 Nov 2021.